Unknown

Dataset Information

0

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.


ABSTRACT: The HIV-1 reservoir is composed of cells harboring latent proviruses that have the potential to contribute to viremia upon antiretroviral treatment (ART) interruption. While this reservoir is known to be maintained by clonal expansion of infected cells, the contribution of these cell clones to residual viremia and viral rebound remains underexplored. Here, we conducted an extensive analysis on four ART-treated individuals who underwent an analytical treatment interruption (ATI), characterizing the proviral genomes and associated integration sites of large infected clones and phylogenetically linking these to plasma viremia. We show discrepancies between different assays in their ability to assess clonal expansion. Furthermore, we demonstrate that proviruses could phylogenetically be linked to plasma virus obtained before or during an ATI. This study highlights a role for HIV-infected cell clones in the maintenance of the replication-competent reservoir and suggests that infected cell clones can directly contribute to rebound viremia upon ATI.

SUBMITTER: Cole B 

PROVIDER: S-EPMC9745684 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.

Cole Basiel B   Lambrechts Laurens L   Boyer Zoe Z   Noppe Ytse Y   De Scheerder Marie-Angélique MA   Eden John-Sebastian JS   Vrancken Bram B   Schlub Timothy E TE   McLaughlin Sherry S   Frenkel Lisa M LM   Palmer Sarah S   Vandekerckhove Linos L  

Cell reports 20220401 4


The HIV-1 reservoir is composed of cells harboring latent proviruses that have the potential to contribute to viremia upon antiretroviral treatment (ART) interruption. While this reservoir is known to be maintained by clonal expansion of infected cells, the contribution of these cell clones to residual viremia and viral rebound remains underexplored. Here, we conducted an extensive analysis on four ART-treated individuals who underwent an analytical treatment interruption (ATI), characterizing t  ...[more]

Similar Datasets

| S-EPMC7260031 | biostudies-literature
| S-EPMC5764487 | biostudies-literature
| S-EPMC8211655 | biostudies-literature
| S-EPMC9464709 | biostudies-literature
2018-01-01 | GSE98902 | GEO
| S-EPMC6289896 | biostudies-literature
| S-EPMC7325710 | biostudies-literature
| S-EPMC10985789 | biostudies-literature
| S-EPMC3126205 | biostudies-literature